Drug Pipeline

Efavirenz Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
2
Recruiting
1
Phase 3
4
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-03 NCT07570069
Effects of Efavirenz on the Pharmacokinetics of Suzetrigine in Healthy Participants		 Recruitment opened
Active Studies by Phase
Phase 3
1
Phase 1
2
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07482085 Efavirenz for the Treatment of Creutzfeldt-Jakob Disease Creutzfeldt-Jakob Disease Not Yet Recruiting
Phase 1
NCT07570069 Effects of Efavirenz on the Pharmacokinetics of Suzetrigine in Healthy Participants Pain Recruiting
NCT07341672 A Single-center, Randomized, Open-label, Parallel-design Clinical Study to Evaluate the… Healthy Adult Subject Not Yet Recruiting
Not specified
NCT06823596 The T Cell Activator of Cell Killing ("TACK") IT ON" STUDY Hiv Recruiting
Sponsors Running Efavirenz Trials
University of Toronto (1) Sunshine Lake Pharma Co., Ltd. (1) Xuanwu Hospital, Beijing (1) Vertex Pharmaceuticals Incorporated (1)
Get alerts when Efavirenz trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free